Tuesday, November 4, 2014

NEW ISSUE OF THE GAZETTE
Hi everybody!
  Please click on the link below the image of the cover below to view the new issue of the 12 Step Gazette.  Any questions or concerns, please do not hesitate to contact us.
  Hope you enjoy it!!



 
http://www.12stepgazette.com/pdf/12StepGazette_NOV-DEC14.pdf

Thanks!
--
Bruce Huberman
12stepgazette@comcast.net
Publisher/Editor
12StepGazette.com
215-317-8774

Sunday, November 2, 2014



November 2 Chp 91 v 6 TWELVE STEPPING WITH STRENGTH FROM THE PSALMS


Do not dread the disease that stalks in darkness ,nor the disaster that strikes at midday. 



STEP 11 - Sought through prayer and meditation to improve our conscious contact with God as we understood God, praying only for knowledge of God's will for us and the power to carry that out.


Like a shark lurking in the darkness is what my addiction was. I can never forget who I am in God and the dark waters he pulled me out of. There are days when my heart is wounded and it bleeds ,that blood causes the sharks to swarm . If I am not careful I would be devoured by a disaster that strikes at midday . That injury received is not worth jumping back into the dark waters and swimming with sharks. I can gracefully walk along the shores confident and unafraid of the those sharks stalking in the darkness as long as I keep my eyes on Him and not them.


Matthew 14 And Peter answered him and said, Lord, if it be thou, bid me come unto thee on the water. (v. 28)

And he said, Come. And when Peter was come down out of the ship, he walked on the water, to go to Jesus. (v. 29)

But when he saw the wind boisterous, he was afraid; and beginning to sink, he cried, saying, Lord, save me. (v. 30)

And immediately Jesus stretched forth his hand, and caught him, and said unto him, O thou of little faith, wherefore didst thou doubt?(v. 31)

By Joseph Dickerson

How Can It Be - Lauren Daigle

Drug Addiction Montage - Hallelujah By The Canadian Tenors


DEA Proposes to Remove Opiate-Based Medication Naloxegol from Drug Schedule
October 29th, 2014/


The Drug Enforcement Administration (DEA) is proposing to remove the opiate-based medication naloxegol from the federal drug schedule, according to The Hill. The drug is currently considered a Schedule II drug under the Controlled Substances Act because it can be derived from opium alkaloids.

Other Schedule II drugs include heroin, methamphetamine, Adderall and Ritalin.

The Food and Drug Administration (FDA) approved naloxegol (Movantik) this fall for treatment of opioid-induced constipation in adults with chronic non-cancer pain. AstraZeneca, which makes naloxegol, submitted a petition seeking the drug’s removal from the drug schedule. The company stated the drug is not prone to abuse. In its proposal, the DEA agreed.

Anyone caught illegally dealing or possessing drugs on the drug schedule faces criminal penalties. Doctors are restricted in the way they can administer the drugs.

Earlier this year, the DEA announced it will reclassify hydrocodone combination productssuch as Vicodin, in an effort to reduce prescription drug abuse. Under the new rules, patients will be able to receive the drugs for only up to 90 days without receiving a new prescription. In October 2013, the FDA recommended tighter restrictions for hydrocodone combination products.

Under the new rule, hydrocodone combination products will be classified as Schedule II drugs. Currently these products are Schedule III drugs, meaning they can be refilled up to five times, and prescriptions can cover a 180-day period. In most cases, patients who wish to refill their hydrocodone combination prescription will now have to give their pharmacy a prescription from a healthcare provider, instead of having it phoned or faxed in.
logoORGANIZING THE
RECOVERY COMMUNITY
Donate
Best Practices in Serving Underserved Communities in Workforce Engagement for People in Recovery with HIV
Monday November 3, 2014 from 12:00 - 1:30 PM EST

Join Faces & Voices of Recovery for a webinar that will address best practices in workforce engagement for people in underserved communities who are affected by addiction and HIV. Cassandra Collins will draw on her experience at Recovery Consultants of Atlanta, a non-profit, faith-based, peer-led Recovery Community Organization which provides integrated behavioral services, HIV prevention counseling, testing and referral, and workforce development and recovery support services.
Presented by:
Cassandra Collins, MSW, Executive Director, Recovery Consultants of Atlanta

Registration deadline is November 2, 2014. The webinar will be recorded and available online.

HIV and Recovery in the Workforce: How Employment Impacts Health and Prevention 

Wednesday November 5, 2014 from 12:00 - 1:30 PM EST


Join Faces & Voices of Recovery for a webinar that will discuss how employment engagement affects health outcomes for individuals living with HIV; the National HIV/AIDS Strategy (NHAS); its implementation plan; vocational and employment needs for people living with HIV; the impact of employment transitions on health and access to care; and best practices in delivering supportive services to those affected by HIV to enter and stay successfully engaged in the workforce. 

Presented by:
Liza Conyers, Ph.D., CRC, Associate Professor, Penn State University; co-founder, National Working Positive Coalition
Mark Misrok, MS ED, CRC, Co-founder, NY HIV Employment Services Network, Board President, National Working Positive Coalition

Registration deadline is November 4, 2014. The webinar will be recorded and available online.

Help get the word out with our flyer.

These webinars are supported by the Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Treatment.
Faces & Voices Website      Take Action      Our Store      Donate      Contact
b-facebook  b-twitter  b-youtube  b-flickr
Copyright 2013 - Faces & Voices of Recovery